Analyze Diet
Veterinary pathology2020; 57(3); 369-376; doi: 10.1177/0300985820906889

Equine Intestinal Lymphoma: Clinical-Pathological Features, Immunophenotype, and Survival.

Abstract: Lymphoma is the most common intestinal neoplasm in horses, but its clinical-pathological features are poorly characterized. Primary intestinal lymphoma was diagnosed in 20 horses on biopsy samples and further confirmed by postmortem examination in 16 cases. Lymphoma was found in the small intestine in 12 of 20 (60%), in the colon in 5 of 20 (25%), and in both small and large intestines in 3 of 20 (15%) cases. Gross findings included thickening of the intestinal wall (45%), mural nodules or masses (30%), and both thickening and nodules (10%). Cases were classified according to the human World Health Organization classification as enteropathy-associated T-cell lymphoma (EATL) type 1 (40%), EATL type 2 (45%), and T-cell-rich large B-cell lymphoma (TCRLBCL) (15%). With respect to histologic grade, 70% of cases were grade 1 and 30% were grade 2. Of EATLs, the infiltrate was mucosal only (12%), mucosal and submucosal (53%), or transmural (35%). EATL1 was submucosal to transmural (2/8 and 6/8), EATL2 was mucosal to submucosal (3/9 and 6/9), and TCRLBCL was always transmural. Epitheliotropism was present in most EATLs and characterized by single-cell infiltrates within the epithelium in EATL1 and intraepithelial clusters or plaques in EATL2. Median survival was 25 days for EATL1, 90 days for EATL2, and 187.5 days for TCRLBCL; differences were not statistically significant. Of the EATLs, grade 1 had a median survival of 60 days and grade 2 had a median survival of 25 days; differences were not statistically significant.
Publication Date: 2020-03-23 PubMed ID: 32202217DOI: 10.1177/0300985820906889Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study provides an analysis of equine intestinal lymphoma, describing its clinical-pathological features, identifying its immunophenotype, and indicating the survival rates. The focus was on horses diagnosed with this condition, aiming to improve the understanding of this relatively under-studied form of cancer in equines.

Research Method

  • The study was conducted using a sample of 20 horses diagnosed with primary intestinal lymphoma via biopsy samples. Additionally, post-mortem examination was carried out in 16 cases to confirm the diagnosis.
  • The lymphoma was discovered in varying regions of the intestines; 60% in the small intestine, 25% in the colon and 15% in both small and large intestines.
  • The gross findings of the disease were thickening of the intestinal wall, mural nodules or masses, or a combination of both.
  • Based on the human World Health Organization classification, the cases were classified as enteropathy-associated T-cell lymphoma (EATL) type 1, EATL type 2, and T-cell-rich large B-cell lymphoma (TCRLBCL).
  • The grade of the disease was also determined, with grade 1 accounting for 70% of cases and grade 2 for 30%.

Key Findings

  • The study provided a detailed understanding of the spread of lymphoma in affected horses. In EATL, the infiltrate was either only in the mucosal layer, both mucosal and submucosal, or transmural.
  • The epitheliotropism, i.e., the tendency of certain infectious or neoplastic cells to gravitate towards the epithelial layers, was present in most EATL cases. It manifested either as single-cell infiltrates within the epithelium in EATL1, or as intraepithelial clusters or plaques in EATL2.
  • Considerable variations were observed in the median survival rates: 25 days for EATL1, 90 days for EATL2, and 187.5 days for TCRLBCL.
  • On comparing the median survival of EATL based on disease grade, grade 1 cases survived a median of 60 days while grade 2 cases survived a median of 25 days. However, statistical analysis showed these differences were not significant.

Significance of the Study

  • The study effectively enhances knowledge of equine intestinal lymphoma, a topic that has been relatively under-researched.
  • Understanding the clinical pathological features, immunophenotype and survival rate is vital for veterinarians to make informed decisions concerning diagnosis, treatment and prognosis of the condition.
  • By initiating discussions on the subject, the authors hope to encourage further research into this neoplasm and its implications for the equine population.

Cite This Article

APA
Bacci B, Stent AW, Walmsley EA. (2020). Equine Intestinal Lymphoma: Clinical-Pathological Features, Immunophenotype, and Survival. Vet Pathol, 57(3), 369-376. https://doi.org/10.1177/0300985820906889

Publication

ISSN: 1544-2217
NlmUniqueID: 0312020
Country: United States
Language: English
Volume: 57
Issue: 3
Pages: 369-376

Researcher Affiliations

Bacci, Barbara
  • Department of Veterinary Medical Sciences (DIMEVET), University of Bologna, Ozzano dell'Emilia, Italy.
  • Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Stent, Andrew William
  • Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Walmsley, Elizabeth Ann
  • Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Melbourne, Victoria, Australia.

MeSH Terms

  • Animals
  • Colon / pathology
  • Enteropathy-Associated T-Cell Lymphoma / pathology
  • Enteropathy-Associated T-Cell Lymphoma / veterinary
  • Horse Diseases / pathology
  • Horses
  • Immunophenotyping / veterinary
  • Intestinal Neoplasms / pathology
  • Intestinal Neoplasms / veterinary
  • Intestine, Small / pathology
  • Intestines / pathology
  • Lymphoma, Large B-Cell, Diffuse / pathology
  • Lymphoma, Large B-Cell, Diffuse / veterinary
  • Severity of Illness Index
  • Survival Analysis

Citations

This article has been cited 5 times.
  1. Bertram CA, Donovan TA, Bartel A. Mitotic activity: A systematic literature review of the assessment methodology and prognostic value in canine tumors. Vet Pathol 2024 Sep;61(5):752-764.
    doi: 10.1177/03009858241239565pubmed: 38533804google scholar: lookup
  2. Paraschou G, Xue C, Egan R, Bolfa P. Multicentric lymphoma in a donkey with intestinal and bone marrow involvement. BMC Vet Res 2024 Feb 15;20(1):57.
    doi: 10.1186/s12917-024-03903-5pubmed: 38360691google scholar: lookup
  3. Kurokawa A, Yamamoto Y. Immunohistochemical identification of T and B lymphocytes in formalin-fixed, paraffin-embedded tissues of 53 avian species using commercial antibodies. J Vet Med Sci 2023 Oct 19;85(10):1121-1130.
    doi: 10.1292/jvms.23-0255pubmed: 37661384google scholar: lookup
  4. Acevedo HD, Hassebroek AM, Leventhal HR, Duhamel GE, Carvallo FR. Colonic T-cell-rich, large B-cell lymphoma associated with equid herpesvirus 5 infection and secondary trans-colonic fistula in a horse. J Vet Diagn Invest 2023 May;35(3):272-277.
    doi: 10.1177/10406387231155414pubmed: 36786313google scholar: lookup
  5. Mecocci S, Porcellato I, Armando F, Mechelli L, Brachelente C, Pepe M, Gialletti R, Passeri B, Modesto P, Ghelardi A, Cappelli K, Razzuoli E. Equine Genital Squamous Cell Carcinoma Associated with EcPV2 Infection: RANKL Pathway Correlated to Inflammation and Wnt Signaling Activation. Biology (Basel) 2021 Mar 21;10(3).
    doi: 10.3390/biology10030244pubmed: 33801021google scholar: lookup